Predicting prognosis and drug sensitivity in patients with hepatocellular carcinoma using an lncRNA signature associated with cuproptosis
Abstract Background Hepatocellular carcinoma (HCC) is a prevalent type of malignant tumor known for its aggressive proliferation and invasive behavior. The exact molecular mechanisms underlying HCC development and progression remain unclear. Nevertheless, cuproptosis has been linked to a range of di...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-05-01
|
| Edice: | BMC Cancer |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12885-026-16132-w |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|